Dr Reddys Laboratories RDY
NYSE RDY
$12.26 -0.36 (-2.85%)
As of: Oct 1, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Gross Profit (2009 - 2026)

Updated

Dr Reddys Laboratories' Gross Profit came in at $396.53 million for the quarter ended Jun 30, 2026, down 30.2% from $568.19 million a year earlier but up 7.6% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Gross Profit (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Dr Reddys Laboratories reported Gross Profit of $1.84 billion, down 18.7% year-over-year; for the year ended Mar 31, 2026, it was $1.89 billion, down 15.3% from the prior year.

  • Gross Profit carries a five-year compound annual growth rate of 6.0% (years ended Mar 2021 to Mar 2026).
  • Going back by year, Gross Profit was $2.23 billion in the year ended Mar 31, 2025 (+13.6%), $1.96 billion in the year ended Mar 31, 2024 (+15.8%), $1.7 billion in the year ended Mar 31, 2023 (+13.0%) and $1.5 billion in the year ended Mar 31, 2022 (+6.5%).
  • The five-year range for quarterly Gross Profit is $337.26 million (the quarter ended Jun 30, 2022) to $580.96 million (the quarter ended Dec 31, 2024).
  • Year-over-year, Gross Profit has declined for four consecutive quarters, with an average decline of 4.1% over the last eight quarters.
  • The fastest year-over-year change in Gross Profit over five years came in the quarter ended Jun 30, 2023 (growth of 44.1%), and the weakest in the quarter ended Mar 31, 2026 (a decline of 32.5%).
  • Business Quant data shows RDY's Gross Profit at $368.55 million (quarter ended Mar 31, 2026), $525.61 million (quarter ended Dec 31, 2025) and $551.91 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Dr Reddys Laboratories 10.53 Bn 9.72 Bn 396.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 396.53 Mn
Mar 31, 2026 368.55 Mn
Dec 31, 2025 525.61 Mn
Sep 30, 2025 551.91 Mn
Jun 30, 2025 568.19 Mn
Mar 31, 2025 545.79 Mn
Dec 31, 2024 580.96 Mn
Sep 30, 2024 570.33 Mn
Jun 30, 2024 555.56 Mn
Mar 31, 2024 499.52 Mn
Dec 31, 2023 506.85 Mn
Sep 30, 2023 488.33 Mn
Jun 30, 2023 486.00 Mn
Mar 31, 2023 476.00 Mn
Dec 31, 2022 439.00 Mn
Sep 30, 2022 488.00 Mn
Jun 30, 2022 337.26 Mn
Mar 31, 2022 382.26 Mn
Dec 31, 2021 379.00 Mn
Sep 30, 2021 377.00 Mn
API Access

Dr Reddys Laboratories Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=RDY&period=max&api_key=YOUR_API_KEY